Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 1;22(10):675-679.
doi: 10.1093/ijnp/pyz048.

(R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress

Affiliations

(R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress

Jiancheng Zhang et al. Int J Neuropsychopharmacol. .

Abstract

Background: A recent study demonstrated that spine formation rates by ketamine in the prefrontal cortex (PFC) were not altered at 3-6 h following a single injection, but were markedly altered at 12-24 h. Here, we investigated the acute (3 h post-treatment) effects of (R)-ketamine in the decreased spine density in the medial PFC (mPFC) and hippocampus in susceptible mice after chronic social defeat stress (CSDS).

Methods: (R)-ketamine (10 mg/kg) or saline was administered intraperitoneally to CSDS-susceptible mice. Dendritic spine density in the mPFC and hippocampus was measured 3 h after a single injection.

Results: (R)-ketamine significantly ameliorated the decreased spine density in the prelimbic area of mPFC, Cornu Ammonis3, and dentate gyrus of the hippocampus of CSDS-susceptible mice.

Conclusions: This study suggests that (R)-ketamine rapidly ameliorates the decreased spine density in the mPFC and hippocampus of CSDS-susceptible mice, resulting in its rapid-acting antidepressant effects.

Keywords: (R)-ketamine; Rapid-acting antidepressant; dendritic spine density; hippocampus; medial prefrontal cortex.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schedule of CSDS, treatment, and brain collection. CSDS was performed from Day 1 to Day 10. A social interaction test was performed on Day 11 to select susceptible mice. On Day 12, saline (10 ml/kg) or (R)-ketamine (10 mg/kg) was administered i.p. to susceptible mice. Saline (10 ml/kg) was also administered i.p. to control (no CSDS) mice. Golgi-Cox staining in the control mice and CSDS-susceptible mice was performed 3 hours after a single administration of saline or (R)-ketamine. Abbreviations: CSDS, chronic social defeat stress; D, day; i.p., intraperitoneal.
Figure 2.
Figure 2.
Rapid effects of (R)-ketamine on the decreased dendritic spine density in the prefrontal cortex and hippocampus in susceptible mice after CSDS. (A-E) Dendritic spine density in the PrL and IL regions of the mPFC, CA1, CA3, and DG of the hippocampus. The bar is 10 μm. (A) PrL region of mPFC (1-way ANOVA, F2,21 = 4.825; P = 0.019). (B) IL region of mPFC (1-way ANOVA, F2,21 = 0.027; P = 0.973). (C) CA1 of hippocampus (1-way ANOVA, F2,21 = 0.019; P = 0.982). (D) CA3 of hippocampus (1-way ANOVA, F2,21 = 8.144; P = 0.002). (E) DG of hippocampus (1-way ANOVA, F2,21 = 14.070; P < 0.001). The values represent the mean ± standard error of the mean (n = 8/group). #P < 0.05, ##P < 0.01, and ###P < 0.001, compared with saline-treated CSDS-susceptible mice. Abbreviations: ANOVA, analysis of variance; CSDS, chronic social defeat stress; DG, dentate gyrus; IL, infralimbic; mPFC, medial prefrontal cortex; N.S., not significant; PrL, prelimbic; R-KT, (R)-ketamine.

Similar articles

Cited by

References

    1. Chang L, Zhang K, Pu Y, Qu Y, Wang SM, Xiong Z, Ren Q, Dong C, Fujita Y, Hashimoto K (2019) Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav 181:53–59. - PubMed
    1. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56. - PMC - PubMed
    1. Dong C, Zhang JC, Yao W, Ren Q, Ma M, Yang C, Chaki S, Hashimoto K (2017) Rapid and sustained antidepressant action of the mGlu2/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine. Int J Neuropsychopharmacol 20:228–236. - PMC - PubMed
    1. Duman RS, Aghajanian GK (2012) Synaptic dysfunction in depression: potential therapeutic targets. Science 338:68–72. - PMC - PubMed
    1. Duman CH, Duman RS (2015) Spine synapse remodeling in the pathophysiology and treatment of depression. Neurosci Lett 601:20–29. - PMC - PubMed

Publication types